CLINICAL_TRIALS
trial_result
· 2021-08-02
Clinical Trial Update: A Phase 2 Study To Assess The Efficacy, Tolerability, And Safety OF NKTR-181 In Subjects With Chronic OA Knee Pain [Phase 2]
Summary
Phase 2 study evaluating NKTR-181 for osteoarthritis of the knee has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Nektar Therapeutics | Conditions: Osteoarthritis of the Knee | Phase 2 | Status: COMPLETED | Results posted: 2021-08-02